Related Articles
Role of hypoxia‑inducible factor‑2α in lung cancer (Review)
Hypoxia-inducible factor: Achilles' heel of antiangiogenic cancer therapy (Review)
Advances in the targeting of HIF-1α and future therapeutic strategies for glioblastoma multiforme (Review)
HIF‑1α in cerebral ischemia (Review)
Hostile takeover: Manipulation of HIF-1 signaling in pathogen-associated cancers (Review)